The effects of prostacyclin (PGI2) were studied in isolated cat basilar and middle cerebral arteries and in human pial arteries. In feline vessels with low resting tension, PGI2 had a contractile effect that reached a maximum of 132% (basilar artery) and 23% (middle cere bral artery) of the potassium-induced (127 mM) contrac tion. In potassium-contracted feline vessels, PGI2 caused a further contraction. When these vessels were con tracted by PGF2a, PGI2 induced relaxation, which was most marked in the middle cerebral artery. PGI2 consis tently relaxed the middle cerebral artery contracted by the prostaglandin endoperoxide analogue U-44069, whereas the basilar artery was almost unaffected. In human pial arteries with low resting tension, PGI2 had no effects in concentrations below 10-6 M, whereas higher concentrations induced contractions. In potassium-
contracted (35 or 127 mM) preparations, PGI2 in concen trations below 10-6 M produced relaxation; in higher con centrations further contraction was induced. Human pial arteries contracted by PGF2a, U-44069, noradrenaline, or 5-hydroxytryptamine consistently relaxed in response to PGI2 « 10-6 M). The PGI2 metabolite 6-keto-PGEt had effects similar to those of PGI2, but proved to be less potent on human pial vessels. 6-Keto-PGFta was ineffec tive, whereas 6,15-diketo-PGFta had minor relaxant ef fects. The results suggest that consideration must be given to regional as well as species differences concerning the cerebrovascular effects of PGI2• Key Words: Feline cerebral arteries-Human pial arteries-Prostacyclin Prostacyclin metabolites-Species and regional differ ences.
subintimal layers of the vessel wall (Moncada et al. , 1977b) . There is abundant evidence that pial vessels are capable of producing PGI2 (Abdel-Halim, 1980; Maeda et al. , 1981; Sasaki et al. , 1981) .
Pronounced effects of PGI2 have been demon strated in peripheral blood vessels in vitro and in various peripheral vascular regions in vivo (Mon cada and Vane, 1978; Moncada, 1982) . Investiga tions of the effect of PGI2 on cerebral vessels have mainly pointed at a dilatational action Chapleau and White, 1979; Ellis et al., 1979; Jarman et al. , 1979; Aitken et al., 1980; Chapleau et al. , 1980; Toda 1980) and an increase in cerebral blood flow (Branan et al., 1979; Pickard et al. , 1980) . PGI2 is produced from the same precur sor as several prostanoids with potent vasocon strictor properties. Vascular tone may depend on a balance between vasodilatational and constrictive prostanoids (Moncada and Vane, 1978) . Since inti mal changes in pial vessels have been observed after experimental subarachnoid hemorrhage (SAH) (Alksne and Smith, 1977; Tanabe et al., 1978; Alksne and Branson, 1980) a PGI2 deficiency may be involved in the pathogenesis of delayed cerebral vasospasm encountered in humans with aneurysmal SAH (Boullin and Blaso, 1977; Boullin et aI. , 1979; Jarman et aI. , 1979; Brandt et aI., 1981; Sasaki et aI., 1981; Quintana et aI., 1982) . In support of this view, Sasaki et a1. (1981) and Maeda et a1. (1981) found a reduced capacity to synthesize PGI2 in ca nine basilar arteries (BAs) after experimental SAH.
PGI2 is chemically unstable and is rapidly hydro lyzed to 6-keto-PGFla in aqueous solution at neutral pH (Moncada and Vane, 1978) . Evidence has been presented that PGI2 may be metabolized to 6-keto PGE1 (Quilley et aI., 1980; Wong et aI. , 1980 Wong et aI. , , 1981 or to 6,15-diketo-PGFla (Wong et aI., 1978) . The former is stable in aqueous solution and exerts a considerable vasodilatational effect (Coceani et aI. , 1980; Nandiwada et aI. , 1980; Quilley et aI. , 1980; Wong et aI. , 1981) . Thus, it is possible that 6-keto PGE1 accounts for at least a part of the vasomotor activity ascribed to PGI2• The present study was performed in order to evaluate further the effects of PGI2 and three PGI2 metabolites (6-keto-PGF 10 , 6-keto-PGE1, and 6-15diketo-PG F 10) on isolated feline and human cerebral vessels. Particular attention was given to regional and species differences, and to the possibility that the PGI2 metabolites may contribute to the vaso motor activity ascribed to PGI2• These factors may be of considerable importance for the understanding and interpretation of the effects of PGI2 on the cere bral vasculature.
MATERIALS AND METHODS

Animals
Specimens of feline cerebral arteries were obtained from 18 adult cats (2.2-3.5 kg body weight), which were exsanguinated under sodium pentobarbital anaesthesia (Nembutal®, 30 mg/kg, i.p.). The brain was removed and the arteries were dissected out carefully under the microscope and then immediately immersed in cooled (+4°C) Krebs solution (for composition, see below). The middle cerebral arteries (MCAs) and BAs either were used immediately or stored in the buffer solution at +4°C for up to 24 h. In addition, small pial arteries were removed from the cortical surface and treated simi larly.
Human material
Human pial vessels were removed from macroscopi cally normal parts of brain cortex before lobe resections were performed in nine patients with an underlying glioma. None of the patients had arterial hypertension. All patients were treated with betamethasone, in some cases phenytoin as well, and were operated under general anaesthesia (fentanyl, thiopental, and pancuronium). The vessel segments were removed together with small parts of adjacent normal cortex and immediately immersed in cooled Krebs solution. The specimens were then trans ported to the laboratory (arriving within 10 to 15 min). The arteries were freed carefully from surrounding tissues under the microscope and, thereafter, either were used immediately or stored as described above.
Preparation and recording of effects
Arterial segments, approximately 300-400 ILm wide (outer diameter) and 2-3 mm long, were suspended be tween two L-shaped metal prongs in organ baths, each containing 5 ml of a Krebs solution. It has recently been demonstrated in our laboratory that cerebral arteries of a size down to approximately 100 ILm (outer diameter) can be mounted with this procedure without causing any damage to the endothelium (Hogestatt et aI., 1982) . The bath solution was continuously bubbled with 5% CO2 in O2, producing a pH of 7.4, and was maintained at 37°C. One of the two metal prongs was connected to a force transducer (Grass FT 03 C) for recording of isometric tension, and the other prong was fixed to a displacement device. Mechanical activity was recorded on a polygraph (Grass Model 7 B). Each vessel was given a tension of approximately 4 mN and allowed to accommodate for 90-120 min, during which time the fluid was replaced every 15 min (for further details, see Hogestatt et aI. , 1981 Hogestatt et aI. , , 1982 .
Solutions
The composition of the Krebs solution was (mM): NaCI, 119; NaHC03, 15; KCI, 4.6; CaCI2, 1. 5; NaH2P04, 1.2; and glucose, 11.0. High-potassium solutions con taining 35 or 127 mM K+ were obtained by exchanging NaCI in the Krebs solution with equimolar amounts of KCl.
Drugs
PGI2 sodium salt (Upjohn, U.S.A.) was dissolved in acetone and dispensed in test tubes. The acetone was rapidly evaporated under a stream of nitrogen, leaving the pure PGI2 salt in the test tubes. This salt was then stored at -20°C and dissolved in ice-cold 0. 05 M Tris buffer solution (pH 10.4) immediately before use. Dilu tions were made up in the same solvent, and the PGI2 solutions were kept on ice thereafter until added to the organ baths in amounts of 25 ILL 6-keto-PGF la' 6-keto PGE1, and 6, 15-diketo-PGFla (Upjohn, U. S.A. ) were dis solved in acetone, dispensed, and stored as described for PGI2• The PGI2 metabolites were redissolved in Tris buffer, and further dilutions were made with phosphate buffer. A stock solution of the prostaglandin en doperoxide analogue U-44069 [(l5S)-hydroxy-9a,lla (epoxymethano)prosta-5Z,13E-dienoic acid] (Upjohn, U.S. A. ) was made up in absolute ethanol (10 mg/ml) and stored at -20°C. PGF 2a was supplied as an aqueous solu tion (Amoglandin®; Astra, Sweden). Fresh dilutions were made each day with phosphate buffer at neutral pH, and kept in the refrigerator until immediately prior to use. Noradrenaline (L-arterenol hydrochloride) (NA) and 5hydroxytryptamine (5-hydroxytryptamine-creatinine sul phate) (5-HT) were obtained from Sigma. The concentra tions of prostanoids are given as concentrations of the free acid in the organ bath. The concentrations of the amines are given as concentrations of free base.
Experimental procedure
To avoid gross changes in the pH of the fluid in the organ baths, PGI2 was added in single doses (25 J.Ll). The baths were rinsed at least twice before the next dose was added. As checked in separate experiments, the concen tration of Tris buffer in the organ bath did not affect the resting vessel tension. Contracted vessels sometimes reacted with a further minute contraction after addition of Tris buffer. The PGI2 metabolites were added cumula tively. Their solvent (phosphate buffer) did not affect resting vessel tension in human or feline preparations.
However, feline MCAs that were contracted by 35 mM K+ or PGF2a were relaxed by 5 ± 0.4% and 10 ± 2% (n = 10), respectively, in response to phosphate buffer. This mean relaxation was subtracted from the response ob tained by the substances tested.
The contraction obtained with the depolarizing solution containing 127 mM K+ was set at 100%, and all sub sequent contractile responses were related to this value. The responses were characterized further with regard to drug concentrations resulting in half-maximum con traction or relaxation (EC50). The maximum responses (Em) that could be obtained were also determined. Calcu lations of the EC50 values were based on the geometrial means. Results are presented as means ± SEM.
RESULTS
Effects of PGI2 on feline cerebral arteries
Under resting conditions, PGI2 produced a concentration-dependent contraction of the BA (Fig. lA) . The "threshold concentration" for con traction was 2.5 x 10-9 M (this concentration of PGI2 consistently induced contractions ranging from 1 to 15%), the EC50 value was 1.4 x 10-6 M (-log EC50 = 5. 9 ± 0. 1), and the Em value was 132 ± 11% of the potassium-induced contraction (n = 7). Pretreatment with the cyclooxygenase inhibitor indomethacin (10-6 M) did not change this reaction pattern. Contraction by PGI2 (2.5 X 10-5 M) reached 94 ± 9% after indomethacin pretreatment, as compared to 91 ± 7% in controls (n = 4). Com pared to the BA, the MCA was less sensitive to the PGI2-induced contraction. In the MCA, the con traction was sometimes preceded by a weak relaxa tion appearing at about 10-7 M PGI2 (Fig. lA) . In the highest PGI2 concentration used (2. 5 x 10-5 M), the contraction of the MCA amounted to 23 ± 11% of the potassium-evoked response (n = 5).
In other experiments, the vessels were contracted by either 35 or 127 mM K+, U-44069 (3 x 10-6 M), 1983 or PGF2a (2 x 10-5 M). In preparations contracted by 35 mM K+, PGI2 caused further contraction of the BA (Fig. lB) . PGI2 relaxed four of eight prepa rations when contractions had been produced by U -44069. No change was observed in the remaining four preparations (Fig. ID) . The overall relaxant Em value was 10 ± 4% (n = 8). A consistent but moder ate (about 18%) relaxant effect was observed in PGF2a-contracted preparations (Fig. lC; Table 1 ).
In the MCA contracted by 35 mM K+, PGI2 in concentrations up to 10-7 M had no consistent ef fects (Fig. lB) . At higher concentrations of PGI2, contractions were seen regularly. PGI2 did not relax either the MCA or small pial arteries contracted by 35 or 127 mM K+. In the MCA contracted by 2 x 10-5 M PGF2", or 3 x 10-6 M U-44069, a concentra tion-dependent relaxation was consistently obtained (Figs. lC,D; Table O . Pretreatment with indometh acin (10-6 M) did not affect this pattern of reaction. In PGF2 -contracted vessels, PGI2 (2.5 x 10-6 M) caused a '" relaxation of 55 ± 12% after indomethacin pretreatment and of 49 ± 5% in controls (n = 4). In arteries contracted by NA (10-4 M) or 5-HT (10-5 M), PGI2 up to 5 X 10-7 M had no consistent relaxant effect (Fig. 2) . In higher concentrations PGl2 induced further contractions.
Effects of PGI2 on human pial arteries PGI2 in low concentrations « 10-6 M) had no consistent effect when added to pial vessels under resting conditions. In concentrations above 10-6 M, PGI2 had a contractile effect (Fig. lA) .
In potassium-contracted preparations, PGI2 had a maximum relaxant effect at a concentration of 10-6 M (Fig. IB) . The Em value for the relaxant effect was 50 ± 8% of the potassium-induced (35 mM) contraction and the EC50 value was 4. 3 x 10-8 M (-log EC50 = 7.4 ± 0.11; n = 4). When contrac tions were produced by 127 mM K+, the maximum relaxation obtained was 18 ± 3%, and the EC50 value was 2.9 x 10-8 M (-log EC50 = 7. 5 ± 0. 06; n = 3). PGI2 produced contractions at lower concen trations in vessels contracted by 127 mM K+ than in vessels contracted by 35 mM K+.
PGF2a-contracted arteries relaxed in response to PGI2 ( Fig. lC; Table 1 ). If contraction was induced by U-44069, the relaxation was less pronounced (Em = 26 ± 1%, n = 4; Fig. ID) . PGI2 « 10-6 M) con sistently relaxed human vessels contracted by either NA or 5-HT (Fig. 2) . This relaxation some times reached values below those of the initial rest ing tension. When PGI2 in concentrations exceeding 10-6 M was added to NA-or 5-HT-contracted ves sels, further contractions were induced. 
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The responses are characterized by the EC50 values (and the negative log of the EC50 values) and the maximal relaxation (Em), expressed as percent reduction of PGF",-induced contraction and presented as mean values ± SEM; n, number of experiments.
Effects of PGI2 metabolites
After potassium-induced contractions, 6-keto PGFJa and 6-keto-PGE1 (3 x 10-5 M) contracted the resting feline BA by 54 ± 8% (n = 5) and 73 ± 22% (n = 6), respectively. 6,15-Diketo-PGFJa (3 x 10-9 to 3 X 10-5 M) had no effect. In BA preparations contracted by potassium or PGF2n, none of the three PGI2 metabolites had any relaxant effect, whereas further minor contractions were seen in re sponse to 6-keto-PGFJa and 6-keto-PGE1 in K+ contracted vessels. No effect was observed in the feline MCA under resting conditions. Minor (�6%) relaxant effects were seen in the MCAs contracted by 35 mM K+ after addition of 6-keto-PGF Ja, 6keto-PGE1, or 6,15-diketo-PGFJa. The relaxant ef fects were more pronounced in PGF2n-contracted MCAs (Fig. 3 ; Table 1 ).
The three PGI2 metabolites exerted no significant effects on resting human pial arteries. 6-Keto-PGE1 relaxed vessels contracted by 35 mM K+ (69 ± 9%), and the EC50 value was 2. 3 x 10-7 M (-log EC50 = 6. 6 ± 0. 06, n = 4; Fig. 4 ). 6-Keto-PGFJa was with out consistent effect, whereas 6, 15-diketo-PGF Ja relaxed the arteries by 15 ± 5% (n = 3). Similar responses were observed in PGF2,,-contracted preparations ( Fig. 3 ; Table 1 ). In vessels contracted by 127 mM K+, the relaxation induced by 6-keto PGE1 ranged from 8 to 37% (n = 5).
DISCUSSION
Most previous studies concerning the cere brovascular effects of PGI2 have demonstrated re laxant effects (Boullin et al. , 1979, human and ba boon BA in vitro; Chapleau and White, 1979, canine BA in vitro; Ellis et al. , 1979, cat in vivo; Jarman et aI. , 1979, baboon in vitro and in vivo; Aitken et al., 1980, rat in vivo; Chapleau et al. , 1980, canine BA in vitro; Pickard et al. , 1980, baboon in vivo; Toda 1980, canine in vitro) . However, there have been observations of a contractile effect of PGI2 on peripheral blood vessels (Dusting et al. , 1977, pig coronary artery in vitro; Levy, 1978, human saphenous, rat portal, and caval veins in vitro) . In the present study, PGI2 was shown to produce strong contractions of the isolated feline BA under resting conditions. In high concentrations, similar effects were observed in the isolated feline MCA � � � and human cortical arteries. The present series of experiments revealed a marked difference in the re sponse to PGI2 between contracted feline BA and MCA. When contractions had been induced by U-44069, the MCA regularly relaxed in response to PGI2, whereas the BA did not consistently relax.
The reason for the variability in the response to PGI2 of the BA is unclear. Also, in PGF2acontracted vessels PGI2 had a more marked relax ant effect on the MCA than on the BA. The dis crepancies in the responses to PGI2 between the BA and MCA may indicate quantitative regional differ ences in the action of PGI2• It is assumed that vasoconstrictor PGs contribute to the maintenance of tone in the cerebral vascula ture (Pickard and MacKenzie, 1973; Ellis et aI. , 1979; Hagen et aI. , 1979; Pickard, 1981) . The pres ent results support this concept. PGs have been proposed to function as modulators of the sympa thetic nervous system and as attenuators of the va soconstrictor effects of angiotensin II (N asjletti and Malik, 1981) . In the present study, PGI2 relaxed feline MCA contracted with prostanoid agents (PGF2a or U-44069) consistently and to a consider able degree, but inconsistently when contracted by -60
Human NA or 5-HT (PGI2 concentrations up to 5 X 10-6 M). The possibility cannot be excluded that these relaxant effects were due to PGI2 competing with PGF2a or U-44069 for the same contracting pros tanoid receptor, since PGI2 did not produce any consistent relaxant effects on vessels contracted by potassium, NA, or 5-HT. It has previously been demonstrated that topical application of PGI2 in duces dilatation of supratentorial feline pial arterioles (Ellis et aI. , 1979) . The possible role of endogenous "protectors" against excessive vasoconstriction has been attributed mainly to the E-prostaglandins, but PGI2 may also have a similar role (Nasjletti and Malik, 1981) . It has been suggested that PGI2 can reduce vascular contractility by inhibiting the re lease of N A from adrenergic nerves (Weitzell et aI. , 1978; Schror et aI., 1981) . On the other hand, an inability of PGI2 to inhibit NA release in the kidney has been described (Hedqvist, 1979) . Previous studies on isolated pial arteries from humans (Brandt et aI., 1981) , baboons (Jarman et aI. , 1979) , and dogs (Chapleau and White, 1979; Chapleau et aI. , 1980) have revealed that PGI2 may produce a biphasic response: a relaxation at low concentrations followed by a contraction at higher concentrations. The present study confirms that PGI2 induces a biphasic response in isolated human pial arteries. Boullin et aI. (1979) reported consis tent relaxant effects of PGI2 in human basilar ar teries obtained at autopsy. However, the highest PGI2 concentration used was 5 x 10-7 M. In the present study, contractions were shown to occur at PGI2 concentrations exceeding 10-6 M.
PGI2 is chemically unstable and has a short lifetime in aqueous solution. Therefore, active sta ble metabolites may contribute to the effects as cribed to PGI2• On human pial arteries, 6-keto-PGE1 had an effect that consistently resembled that of PGI2• 6,15-Diketo-PGF1<x and, in particular, 6keto-PGFtu were much less effective. 6-Keto-PGE1 has been reported to have a considerable dilata tional activity in the peripheral circulation (Coceani et aI. , 1980; Nandiwada et aI. , 1980; Quilley et aI. , 1980; Wong et aI. , 1981) . The enzyme responsible for the synthesis of 6-keto-PGE1 has been demon strated in the liver and in platelets (Quilley et aI. , 1980; Wong et aI., 1980 Wong et aI., , 1981 , but not as yet in brain or in cerebral vessels. The present results show that 6-keto-PGE1 has a relaxant effect on the feline MCA and human pial arteries, but not on the feline BA. However, in human pial arteries in vitro, the potency was only one-tenth that of PGI2• It therefore seems less likely that 6-keto-PGE1 should be responsible for the main part of the effect on human cerebral vessels ascribed to PGI2• In feline MCA, however, 6-keto-PGE1 seems to have at least the same potency (as defined by the EC50 values) as PGI2• PGI2 was capable of relaxing human pial arteries, even after depolarization by 35 or 127 mM K+, but no such effect was found on feline vessels. This also was true for small feline cortical arteries removed from regions of the brain corresponding to the re gions from which the human pial vessels used in the study were obtained. Furthermore, PGI2 (in concen trations up to 5 X 10-6 M) had no consistent relax ant effect on feline MCA contracted by NA or 5-HT, in contrast to its very pronounced relaxant effect on human pial arteries contracted by these amines. The reason for these discrepancies remains obscure. One might speculate that different in tracellular mechanisms mediating PGI2-induced re laxation are involved in vessels from different species.
The data of the present study suggest important differences in vascular reactivity between human and feline cerebral vessels, as well as regional dif ferences in the reaction of feline cerebral arteries. These facts should be taken into consideration when results obtained in animal models are used to J Cereb Blood Flow Metabol, Vol. 3, No. 2, 1983 explain the pathophysiology of human cerebrovas cular disease.
